Table 3. Antibiotic resistance of AmpC producers K. pneumoniae and E. coli isolates.
Antibiotic |
K. pneumoniae
n=6 (%) |
E. coli
n= 3 (%) |
---|---|---|
Amikacin | 0 (0) | 0 (0) |
Gentamicin | 4 (66.6) | 1 (16) |
Ertapenem | 2 (33.3) | 0 (0) |
Imipenem | 2 (33.3) | 1 (33.3) |
Meropenem | 2 (33.3) | 0 (0) |
cefoxitin | 6 (100) | 3 (100) |
ceftazidime | 6 (100) | 2 (66.6) |
Ceftriaxone | 6 (100) | 3 (13.3) |
Cefepime | 5 (83.3) | 2 (66.6) |
Aztreonam | 6 (100) | 3 (100) |
Ampicillin | 6 (100) | 3 (100) |
Amoxicilli-clavulanate | 6 (88) | 3 (100) |
Piperacillin-Tazobactam | 3 (50) | 1 (33.3) |
Colistin | 0 (0) | 0 (0) |
Trimetoprim-sulfametoxazol | 2 (33.3) | 3 (100) |
Nitrofurantoin | 3 (50) | 0 (0) |
Ciprofloxacin | 3 (50) | 0 (0) |
Levofloxacin | 3 (50) | 0 (0) |